Encounter for antenatal screening for isoimmunization
ICD-10 Z36.5 is a billable code used to indicate a diagnosis of encounter for antenatal screening for isoimmunization.
Z36.5 is used to indicate an encounter for antenatal screening specifically aimed at detecting isoimmunization, a condition where a pregnant woman’s immune system produces antibodies against the red blood cells of the fetus. This screening is crucial for preventing hemolytic disease of the newborn, which can lead to serious complications. Factors influencing health status include maternal age, previous pregnancy history, and blood type compatibility. Social determinants such as access to healthcare, socioeconomic status, and education level can impact the likelihood of receiving timely screening. Preventive care through early detection allows for appropriate management strategies, including monitoring and potential interventions like Rh immunoglobulin administration. This code is essential for ensuring that pregnant individuals receive comprehensive care that addresses both medical and social factors affecting their health.
Documentation should include patient history, screening results, and any follow-up care plans.
Routine prenatal visits where screening for isoimmunization is performed.
Consideration of social determinants such as access to prenatal care and education on the importance of screening.
Documentation should focus on population health data, screening rates, and outcomes related to isoimmunization.
Community health initiatives aimed at increasing awareness and screening for isoimmunization.
Tracking health disparities and access to care in different populations.
Used during the prenatal visit when screening for isoimmunization is performed.
Document the reason for the CBC and the results of the isoimmunization screening.
Primary care providers should ensure comprehensive prenatal care documentation.
Screening for isoimmunization is crucial as it helps prevent hemolytic disease of the newborn, which can lead to severe complications. Early detection allows for timely interventions, improving maternal and fetal outcomes.
